BACK

Data on blood clots associated with the AstraZeneca vaccine

This article was published on
June 1, 2021

This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.

The Winton Centre for Risk and Evidence Communication at the University of Cambridge in the UK has published updated graphics on the risks and benefits of the Oxford AstraZeneca vaccine and specific blood clots, in different age groups, and with different virus exposure levels, and also by gender.

The Winton Centre for Risk and Evidence Communication at the University of Cambridge in the UK has published updated graphics on the risks and benefits of the Oxford AstraZeneca vaccine and specific blood clots, in different age groups, and with different virus exposure levels, and also by gender.

Publication

What our experts say

Context and background

Resources

The data can be found here.

Media briefing

Media Release

Expert Comments: 

No items found.

Q&A

No items found.